Transforaminal epidural injection versus continued conservative care in acute sciatica (TEIAS trial): study protocol for a randomized controlled trial

Eduard Verheijen, Alexander G Munts, Oscar van Haagen, Dirk de Vries, Olaf Dekkers, Wilbert van den Hout, Carmen Vleggeert-Lankamp, Eduard Verheijen, Alexander G Munts, Oscar van Haagen, Dirk de Vries, Olaf Dekkers, Wilbert van den Hout, Carmen Vleggeert-Lankamp

Abstract

Background: Sciatica is a condition that is characterised by radicular pain in the leg and primarily caused by a herniated lumbar intervertebral disk. In addition to leg pain, patients can experience back pain, leg numbness and leg weakness resulting in decreased productivity and social activity. The majority of sciatica cases recovers spontaneously and therefore patients are initially treated conservatively with oral pain medication. However, some patients experience intractable pain that severely impedes them and no consensus exists on the optimal conservative treatment to reduce this discomfort in the acute phase of sciatica. The aim of the TEIAS trial is to assess the effectiveness, cost-effectiveness and predictive capability on patient outcome of transforaminal epidural injection (TEI) compared to treatment with standard pain medication.

Methods: This study is designed as a prospective, open-label, mono-centered, randomized controlled trial. Patients that visit their general practitioner with complaints of radicular leg pain and meet the selection criteria are asked to participate in this study. Eligible patients will be randomized to treatment with TEI or to treatment with standard oral pain medication. Treatment of TEI will comprise lidocaine with methylprednisolone acetate for L3 and below and lidocaine with dexamethasone above L3. A total of 142 patients will be recruited and follow-up will occur after 1, 2, 4, 10 and 21 weeks for assessment of pain, functionality, patient received recovery and cost-effectiveness. The primary outcome will be the average score for leg pain at 2 weeks. For this outcome we defined a clinically relevant difference as 1.5 on the 11-point NRS scale.

Discussion: Adequate conservative treatment in the acute phase of sciatica is lacking, particularly for patients with severe symptoms. Focusing on effectiveness, cost-effectiveness and predictive capability on patient outcome of TEI will produce useful information allowing for more lucid decision making in the conservative treatment of sciatica in the acute phase.

Trial registration: This trial is registered in the ClinicalTrials.gov database under registry number NCT03924791 on April 23, 2019.

Keywords: Acute sciatica; Cost-effectiveness; Herniated intervertebral disk; Leg pain; Lumbar spine; Lumbar surgery; Prolonged conservative treatment; Randomized controlled trial; Transforaminal epidural injection.

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Flow diagram of TEIAS study procedures

References

    1. Koes BW, van Tulder MW, Peul WC. Diagnosis and treatment of sciatica. BMJ. 2007;334:1313. doi: 10.1136/.
    1. Konstantinou K, Dunn KM. Sciatica: review of epidemiological studies and prevalence estimates. Spine. 2008;33(22):2454–2472. doi: 10.1097/BRS.0b013e318183a4a2.
    1. Freynhagen R, Baron R. The evaluation of neuropathic components in low Back pain. Curr Pain Headache Rep. 2009;13(3):185–190. doi: 10.1007/s11916-009-0032-y.
    1. Hicks GE, Gaines JM, Shardell M, Simonsic EM. Associations of back and leg pain with health status and functional capacity of older adults: findings from the retirement community back pain study. Arthritis Rheum. 2008;59:1306–1313. doi: 10.1002/art.24006.
    1. Samanta A, Beardsley J. Sciatica: which intervention? BMJ. 1999;319(7205):302–303. doi: 10.1136/bmj.319.7205.302.
    1. Frymoyer JW. Back pain and sciatica. N Engl J Med. 1988;318(5):291–300. doi: 10.1056/NEJM198802043180506.
    1. Lambeek LC, van Tulder MW, Swinkels ICS, Koppes LLJ, Anema JR, van Mechelen W. The trend in Total cost of Back pain in the Netherlands in the period 2002 to 2007. Spine Phila Pa 1976. 2011;36(13):1050–1058. doi: 10.1097/BRS.0b013e3181e70488.
    1. Peul WC, van Houwelingen HC, van den Hout WB, Brand R, Eekhof JA, Tans JT, et al. Surgery versus prolonged conservative treatment for sciatica. N Engl J Med. 2007;356(22):2245–2256. doi: 10.1056/NEJMoa064039.
    1. Hofstede SN, Marang-van de Mheen PJ, Wentink MM, Stiggelbout AM, Vleggeert-Lankamp CL, Vliet Vlieland TP, van Bodegom-Vos L. Barriers and facilitators to implement shared decision making in multidisciplinary sciatica care: a qualitative study. Implement Sci. 2013;8(1):95. doi: 10.1186/1748-5908-8-95.
    1. Hofstede SN, van Bodegom-Vos L, Wentink MM, Vleggeert-Lankamp CL, Vliet Vlieland TP, Marang-van de Mheen PJ. Most important factors for the implementation of shared decision making in sciatica care: ranking among professionals and patients. PLoS One. 2014;9(4):e94176. doi: 10.1371/journal.pone.0094176.
    1. Spijker-Huiges A, Winters JC, van Wijhe M, Groenier K. Steroid injections added to the usual treatment of lumbar radicular syndrome: a pragmatic randomized controlled trial in general practice. BMC Musculoskelet Disord. 2014;15:341. doi: 10.1186/1471-2474-15-341.
    1. Joswig H, Neff A, Ruppert C, Hildebrandt G, Stienen MN. The value of short-term pain relief in predicting the one-month outcome of lumbar Transforaminal epidural steroid injections. World Neurosurg. 2016;96:323–333. doi: 10.1016/j.wneu.2016.09.016.
    1. Joswig H, Neff A, Ruppert C, Hildebrandt G, Stienen MN. The value of short-term pain relief in predicting the long-term outcome of lumbar Transforaminal epidural steroid injections. World Neurosurg. 2017;107:764–771. doi: 10.1016/j.wneu.2017.08.055.
    1. El-Yahchouchi C, Wald J, Brault J, Geske J, Hagen C, Murthy N, Kaufmann T, Thielen K, Morris J, Diehn F, Amrami K, Carter R, Shelerud R, Maus T. Lumbar transforaminal epidural steroid injections: does immediate post-procedure pain response predict longer term effectiveness? Pain Med. 2014;15(6):921–928. doi: 10.1111/pme.12347.
    1. Neal JM, Barrington MJ, Brul R, Hadzic A, Hebl JR, Horlocker TT, Huntoon MA, Kopp SL, Rathmell JP, Watson JC. The second ASRA practice advisory on neurologic complications associated with regional anesthesia and pain medicine: executive summary 2015. Reg Anesth Pain Med. 2015;40:401–430. doi: 10.1097/AAP.0000000000000286.
    1. Katz NP, Paillard FC, Ekman E. Determining the clinical importance of treatment benefits for interventions for painful orthopedic conditions. J Orthop Surg Res. 2015;10(24):1–11.
    1. Section Pain and Palliative Medicine of the Dutch Anesthesiology Association (NVA). Protocol Veilig gebruik van epidurale corticosteroïden infiltraties. 2016. .
    1. Kaye AD, Manchikanti L, Abdi S, et al. Efficacy of epidural injections in managing chronic spinal pain: a best evidence synthesis. Pain Physician. 2015;18(6):939–1004.
    1. Bhatti AB, Kim S. Role of epidural injections to prevent surgical intervention in patients with chronic sciatica: a systematic review and meta-analysis. Cureus. 2016;8(8):723.
    1. Nandi J, Chowdhery A. A randomized controlled clinical trial to determine the effectiveness of caudal epidural steroid injection in lumbosacral sciatica. J Clin Diagn Res. 2017;11(2):4–8.
    1. Guo JR, Jin XJ, Shen HC, Wnag H, Zhou X, Liu XQ, Zhu NN. A comparison of the efficacy and tolerability of the treatments for sciatica: a network meta-analysis. Ann Pharmacother. 2017;51(12):1041–1052. doi: 10.1177/1060028017722008.
    1. Spijker-Huiges A, Vermeulen K, Winters JC, van Wijhe M, van der Meer K. Epidural steroids for lumbosacral radicular syndrome compared to usual care: quality of life and cost utility in general practice. Arch Phys Med Rehabil. 2015;96(3):381–387. doi: 10.1016/j.apmr.2014.10.017.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe